A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with aids1
- 1 April 2002
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 133 (4), 467-474
- https://doi.org/10.1016/s0002-9394(02)01327-2
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Safety of intravitreous fomivirsen for treatment of cytomegalovirus retinitis in patients with AIDSAmerican Journal of Ophthalmology, 2002
- Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDSAmerican Journal of Ophthalmology, 2002
- Ganciclovir resistance and UL97 gene mutations in cytomegalovirus blood isolates from patients with AIDS treated with ganciclovirJournal of Clinical Virology, 1999
- Changing trends in cytomegalovirus retinitis with highly active anti-retroviral therapy (HAART)Eye, 1999
- Fomivirsen – a phosphorothioate oligonucleotide for the treatment of CMV retinitisOcular Immunology and Inflammation, 1999
- Cytomegalovirus retinitis and viral resistance: 3. Culture resultsAmerican Journal of Ophthalmology, 1998
- Cytomegalovirus Retinitis and Viral ResistanceThe Journal of Infectious Diseases, 1998
- Proof of Mechanism of Antisense DrugsAntisense and Nucleic Acid Drug Development, 1996
- Antiviral activity of a phosphorothioate oligonucleotide complementary to human cytomegalovirus RNA when used in combination with antiviral nucleoside analogsAntiviral Research, 1995
- A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Cytomegalovirus Peripheral Retinitis in Patients with AIDSThe Journal of Infectious Diseases, 1993